Safety and Efficacy of CC-10004 for Prurigo Nodularis
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This trial will include:
- Study period up to 7 months.
- Office visits monthly lasting approximately 1 hour.
- Blood Draws.
- Oral medication that is taken 2 times daily.
- Photographs and biopsies if agreed.